Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > Supplier info centre

Vetter Pharma International GmbH

Vetter_Pharma

Vetter Pharma International GmbH

Established: 1953

Number of staff: Approximately 3,000

Key Personnel: Max Horn, managing director; Thomas Otto, managing director; Peter Soelkner, managing director

 

Who we are:

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-ofthe- art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield.

 

Major Markets: Europe & North America

 

Services Offered:

Vetter Development Service includes:

–Formulation support

–Process development

–Clinical trial manufacturing

–Analytical service

–Regulatory support

 

Vetter Commercial Manufacturing includes:

–Fill and finish

–Analytical service

–Regulatory support

–Product life cycle management

 

Vetter Packaging Solutions include:

–Customized packaging development

–Specialized technologies

–Proven platform technologies

–Packaging services

 

Dosage forms: Syringes, cartridges and vials

Contact Details

  • Fax: +49-751-3700-4000
  • Website: www.vetter-pharma.com
  • Address: Vetter Pharma-Fertigung GmbH & Co. KG, Schuetzenstrasse 87, 88212, Ravensburg, Germany